U.S. Markets closed

IsoRay, Inc. (ISR)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.5699+0.01 (+1.68%)
At close: 4:02PM EDT
People also watch
PBMDMNGARNNIBIOAVEO
Interactive chart
Previous Close0.5605
Open0.5692
Bid0.0000 x
Ask0.0000 x
Day's Range0.5600 - 0.5750
52 Week Range0.4800 - 1.0600
Volume69,075
Avg. Volume113,995
Market Cap31.35M
Beta1.54
PE Ratio (TTM)-5.88
EPS (TTM)-0.1
Earnings DateMay 10, 2017 - May 12, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Trade prices are not sourced from all markets
  • IsoRay, Inc. :ISR-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017
    Capital Cube3 days ago

    IsoRay, Inc. :ISR-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis IsoRay, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of IsoRay, Inc. – Accuray Incorporated, General Electric Company, Hologic, Inc., AngioDynamics, Inc., STRATA Skin Sciences, Inc., C. R. Bard, Inc. and Varian Medical Systems, Inc. (ARAY-US, GE-US, HOLX-US, ANGO-US, ... Read more (Read more...)

  • Associated Press19 days ago

    IsoRay reports 3Q loss

    The Richland, Washington-based company said it had a loss of 2 cents per share. The isotope-based medical products maker posted revenue of $1.3 million in the period. The company's shares closed at 57 ...

  • IsoRay Announces Third Quarter Fiscal 2017 Financial Results
    PR Newswire19 days ago

    IsoRay Announces Third Quarter Fiscal 2017 Financial Results

    RICHLAND, Wash. , May 10, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of ...